Telehealth program aims to get HIV treatment to people who inject drugs faster

NCT ID NCT05208697

Completed Disease control Sponsor: University of Miami Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jul 01, 2026 · Updated 3 times

Summary

This study tested two ways to offer HIV treatment, hepatitis C treatment, and substance use disorder medications to people who inject drugs. One group received a telehealth-enhanced program with on-demand services like mobile blood draws and counseling, while the other group got standard care. The goal was to see if the telehealth approach helped more people get their HIV under control and cure hepatitis C.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: telehealth-enhanced harm reduction program
What this could lead to: If successful, this approach could make it easier for people who inject drugs to get HIV under control and treat hepatitis C at the same time.
What could go wrong: This was a small study (100 people) and the results may not apply to everyone. The program relies on telehealth and on-site services, which may not be available everywhere.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEPATITIS C are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

hepatitis C virus infection HIV infectious disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEPATITIS C HIV INFECTIONS IV DRUG USAGE

Contacts and locations

Locations

Care Resource The SPOT

Fort Lauderdale, Florida, 33311, United States
University of Miami

Miami, Florida, 33136, United States
University of South Florida

Tampa, Florida, 33612, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.